CfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infection in general practice: a prospective cohort study.
Saved in:
| Title: | CfDNA as a surrogate marker for COVID-19 severity in patients with influenza-like symptoms with and without SARS-CoV-2 infection in general practice: a prospective cohort study. |
|---|---|
| Authors: | Dehnen D; Institute of General Practice, Medical Faculty, University of Duisburg-Essen, Essen, Germany. dorothea.dehnen@uk-essen.de., Botzenhardt S; West German Cancer Center, University Hospital Essen, Essen, Germany., Giagkou E; Institute of General Practice, Medical Faculty, University of Duisburg-Essen, Essen, Germany., Enders K; Department of Sports Medicine, Rehabilitation and Disease Prevention, Johannes Gutenberg University of Mainz, Mainz, Germany., Hoeter K; Department of Anaesthesiology, University Medical Centre of the Johannes Gutenberg- University, Mainz, Germany., Simon P; Department of Sports Medicine, Rehabilitation and Disease Prevention, Johannes Gutenberg University of Mainz, Mainz, Germany., Neuberger EWI; Department of Sports Medicine, Rehabilitation and Disease Prevention, Johannes Gutenberg University of Mainz, Mainz, Germany. |
| Source: | Virology journal [Virol J] 2025 Dec 01; Vol. 22 (1), pp. 390. Date of Electronic Publication: 2025 Dec 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X (Electronic) Linking ISSN: 1743422X NLM ISO Abbreviation: Virol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
